Lung Cancer

Evidence linking supplemental vitamin B use and lung cancer has been inconsistent. In a recent study, researchers sought to investigate this association among individuals who reported long-term use of...

The American Society of Clinical Oncology (ASCO) has updated its 2015 guidelines on systemic therapy for stage IV non-small-cell lung cancer (NSCLC).

In a recent study, researchers compared the safety, efficacy, and tolerability of 2 treatment combinations for patients with non-small cell lung cancer with brain metastases. To see results of the study,...

A recent study assessed the efficacy of atezolizumab across different lines of therapy in patients with advanced non-small cell lung cancer. For study results, including the objective response rate after 12...

The US Food and Drug Administration has approved the first treatment for a genetic mutation of non-small cell lung cancer, and also approved the diagnostic test for determining multiple genetic mutations...

The FDA has broadened the approval of a non-small cell lung cancer drug, previously approved in 2014.

The FDA approved the first anti-PD-1 therapy to be administered in combination with standard chemotherapy for the treatment of non-small cell lung cancer.

Researchers examined the potential risk of cardiac injury following radiation therapy in patients with stage III non-small-cell lung cancer.

The FDA has approved a new drug for the treatment of patients with metastatic anaplastic lymphoma kinase-positive non-small cell lung cancer.

The FDA approved osimertinib for the treatment of patients with metastatic epidermal growth factor receptor T790M mutation-positive non-small cell lung cancer.